stress reduction intervention in caregivers

一旦受试者被确定并作为计划在NIH临床中心接受同种异体HSCT的个体的主要护理者，则受试者将被纳入本方案。在患者开始其移植预处理之前，接触患者和护理者以参与。需要至少78名护理人员的样本，以充分评估计划的主要分析的干预措施的有效性。招聘于2015年1月开始，目前仍在进行中。 共筛选了152例HSCT患者，47例入组，10例撤回知情同意书，37例完成入组和研究程序。研究继续入组，以满足方案目标。

Subjects are accrued to this protocol once they have been identified and are serving as a primary caregiver for an individual planning to undergo an allogeneic HSCT at the Clinical Center, NIH. The patient and caregiver(s) are approached for participation before the patient starts their transplant conditioning. A sample of at least 78 caregivers is needed to adequately evaluate the effectiveness of the intervention for the planned primary analysis. Recruitment began in January 2015, and remains ongoing at this time. A total of 152 HSCT patients have been screened, 47 enrolled, 10 withdrew consent, and 37 have completed enrollment and study procedures. The study continues to enroll to meet protocol objectives.